120 related articles for article (PubMed ID: 12459522)
1. Compound heterozygosity for the Xeroderma pigmentosum complementation group A gene associated with a mild phenotype.
Negishi I; Kato G; Moriwaki S; Ishikawa O
Eur J Dermatol; 2002; 12(6):536-9. PubMed ID: 12459522
[TBL] [Abstract][Full Text] [Related]
2. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan.
Nishigori C; Moriwaki S; Takebe H; Tanaka T; Imamura S
Arch Dermatol; 1994 Feb; 130(2):191-7. PubMed ID: 7905727
[TBL] [Abstract][Full Text] [Related]
3. A case of xeroderma pigmentosum group A diagnosed with a polymerase chain reaction (PCR) technique. Usefulness of PCR in the detection of point mutation in a patient with a hereditary disease.
Kore-eda S; Tanaka T; Moriwaki S; Nishigori C; Imamura S
Arch Dermatol; 1992 Jul; 128(7):971-4. PubMed ID: 1352672
[TBL] [Abstract][Full Text] [Related]
4. Distribution of mutations in the human xeroderma pigmentosum group A gene and their relationships to the functional regions of the DNA damage recognition protein.
States JC; McDuffie ER; Myrand SP; McDowell M; Cleaver JE
Hum Mutat; 1998; 12(2):103-13. PubMed ID: 9671271
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of the point mutation in exon 6 of the xeroderma pigmentosum group A-complementing (XPAC) gene in xeroderma pigmentosum group A patients in Tunisia.
Nishigori C; Zghal M; Yagi T; Imamura S; Komoun MR; Takebe H
Am J Hum Genet; 1993 Nov; 53(5):1001-6. PubMed ID: 8105686
[TBL] [Abstract][Full Text] [Related]
6. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
[TBL] [Abstract][Full Text] [Related]
7. DNA-based prenatal diagnosis in a Chinese family with xeroderma pigmentosum group A.
Yang Y; Ding B; Wang K; Bu D; Tu P; Zhu X
Br J Dermatol; 2004 Jun; 150(6):1190-3. PubMed ID: 15214909
[TBL] [Abstract][Full Text] [Related]
8. [Neurological manifestations and molecular basis of group A xeroderma pigmentosum].
Mimaki T; Tanaka K; Nagai A; Mino M
Nihon Rinsho; 1993 Sep; 51(9):2488-93. PubMed ID: 8105118
[TBL] [Abstract][Full Text] [Related]
9. Aberrant splicing and truncated-protein expression due to a newly identified XPA gene mutation.
Sato M; Nishigori C; Yagi T; Takebe H
Mutat Res; 1996 Feb; 362(2):199-208. PubMed ID: 8596539
[TBL] [Abstract][Full Text] [Related]
10. Severe neurological abnormalities associated with a mutation in the zinc-finger domain in a group A xeroderma pigmentosum patient.
Maeda T; Sato K; Minami H; Taguchi H; Yoshikawa K
Br J Dermatol; 1994 Oct; 131(4):566-70. PubMed ID: 7947212
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
[TBL] [Abstract][Full Text] [Related]
12. Prenatal diagnosis of xeroderma pigmentosum group A in Japan.
Moriwaki S; Yamashita Y; Nakamura S; Fujita D; Kohyama J; Takigawa M; Ohmichi M
J Dermatol; 2012 Jun; 39(6):516-9. PubMed ID: 22168765
[TBL] [Abstract][Full Text] [Related]
13. Allelic heterogeneity in group A xeroderma pigmentosum.
Mimaki T; Tanaka K; Okada Y; Minami R; Tachi N; Nagai A; Mino M
Acta Neurol Scand; 1992 May; 85(5):327-30. PubMed ID: 1621494
[TBL] [Abstract][Full Text] [Related]
14. A new XPC gene splicing mutation has lead to the highest worldwide prevalence of xeroderma pigmentosum in black Mahori patients.
Cartault F; Nava C; Malbrunot AC; Munier P; Hebert JC; N'guyen P; Djeridi N; Pariaud P; Pariaud J; Dupuy A; Austerlitz F; Sarasin A
DNA Repair (Amst); 2011 Jun; 10(6):577-85. PubMed ID: 21482201
[TBL] [Abstract][Full Text] [Related]
15. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with Xeroderma Pigmentosum: a case report and review of the genetic variants reported in XPC.
Rivera-Begeman A; McDaniel LD; Schultz RA; Friedberg EC
DNA Repair (Amst); 2007 Jan; 6(1):100-14. PubMed ID: 17079196
[TBL] [Abstract][Full Text] [Related]
16. Xeroderma pigmentosum variant: complementary molecular approaches to detect a 13 base pair deletion in the DNA polymerase eta gene.
Hentosh P; Benjamin T; Hall L; Leap S; Loescher J; Poyner E; Sundin T; Whittle M; Wilkinson S; Peffley DM
Exp Mol Pathol; 2011 Oct; 91(2):528-33. PubMed ID: 21640722
[TBL] [Abstract][Full Text] [Related]
17. Three nonsense mutations responsible for group A xeroderma pigmentosum.
Satokata I; Tanaka K; Miura N; Narita M; Mimaki T; Satoh Y; Kondo S; Okada Y
Mutat Res; 1992 Mar; 273(2):193-202. PubMed ID: 1372102
[TBL] [Abstract][Full Text] [Related]
18. U.v.-hypermutability of xeroderma pigmentosum cells demonstrated with a DNA-based mutation system.
Steingrimsdottir H; Beare D; Carr AM; Cole J; Lehmann AR
Oncogene; 1995 May; 10(10):2057-66. PubMed ID: 7761106
[TBL] [Abstract][Full Text] [Related]
19. Mutation spectra induced by alpha-acetoxytamoxifen-DNA adducts in human DNA repair proficient and deficient (xeroderma pigmentosum complementation group A) cells.
McLuckie KI; Crookston RJ; Gaskell M; Farmer PB; Routledge MN; Martin EA; Brown K
Biochemistry; 2005 Jun; 44(22):8198-205. PubMed ID: 15924439
[TBL] [Abstract][Full Text] [Related]
20. Correlation of the clinical manifestations and gene mutations of Japanese xeroderma pigmentosum group A patients.
Kondoh M; Ueda M; Ichihashi M
Br J Dermatol; 1995 Oct; 133(4):579-85. PubMed ID: 7577588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
